Details about Joel W. Hay

Access statistics for papers by Joel W. Hay.

Last updated 2023-03-16. Update your information in the RePEc Author Service.

Short-id: pha1071

Working Papers

1977

1. Educational Screening and Occupational Earnings
   NBER Working Papers, National Bureau of Economic Research, Inc

Undated

2. Where Do I Send Thee? Does Physician-Ownership Affect Referral Patterns to Ambulatory Surgery Centers
   Mathematica Policy Research Reports, Mathematica Policy Research View citations (4)

Journal Articles

2015

1. A Special Commemorative Issue Honoring William S. Comanor and 50 Years of Pharmaceutical Economics
   International Journal of the Economics of Business, 2015, 22, (2), 165-168

2014

2. A Review of the Economic Burden of Glioblastoma and the Cost Effectiveness of Pharmacologic Treatments
   PharmacoEconomics, 2014, 32, (12), 1201-1212 View citations (1)

2013

3. Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
   PharmacoEconomics, 2013, 31, (9), 823-839 View citations (1)
4. Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia
   PLOS ONE, 2013, 8, (11), 1- View citations (1)
5. INCREMENTAL EXPENDITURE OF BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC TREATMENT USING INSTRUMENTAL VARIABLES IN PANEL DATA
   Health Economics, 2013, 22, (7), 807-823

2006

6. Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors as First-Line Agents in Rheumatoid Arthritis
   PharmacoEconomics, 2006, 24, (12), 1221-1232 View citations (5)

2001

7. Embedding Health-Promoting Changes Into the Daily Lives of Independent-Living Older Adults
   The Journals of Gerontology: Series B, 2001, 56, (1), P60-P63 View citations (2)

1994

8. A Procedure for Estimating the Unconditional Cumulative Incidence Curve and its Variability for the Human Immunodeficiency Virus
   Journal of the Royal Statistical Society Series C, 1994, 43, (4), 599-624 View citations (1)
9. The US economic and social costs of Alzheimer's disease revisited
   American Journal of Public Health, 1994, 84, (8), 1261-1264 View citations (3)

1991

10. Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease
    American Journal of Public Health, 1991, 81, (4), 427-433

1989

11. Econometric issues in modeling the costs of AIDS
    Health Policy, 1989, 11, (2), 125-145 View citations (2)

1987

12. Ordinary Least Squares and Sample-Selection Models of Health-Care Demand
    Journal of Business & Economic Statistics, 1987, 5, (4), 499-506 View citations (25)
13. The economic costs of Alzheimer's disease
    American Journal of Public Health, 1987, 77, (9), 1169-1175 View citations (3)

1985

14. Fee-Screen Reimbursement and Physician Fee Inflation
    Journal of Human Resources, 1985, 20, (2), 278-291 View citations (1)

1984

15. Let Them Eat Cake: A Note on Comparing Alternative Models of the Demand for Medical Care
    Journal of Business & Economic Statistics, 1984, 2, (3), 279-82 View citations (42)

1982

16. Physician-induced demand: An empirical analysis of the consumer information gap
    Journal of Health Economics, 1982, 1, (3), 231-244 View citations (21)
17. The demand for dental health
    Social Science & Medicine, 1982, 16, (13), 1285-1289 View citations (7)